837.16USD+1.27%Mkt Cap: 85.11B $P/E: 20.44Today
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammator…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap85.11B $
Enterprise Value77.26B $
Revenue (TTM)15.53B $
Gross Profit12.24B $
Net Income (TTM)4.50B $
Revenue/Share150.31 USD
Last Price837.16 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15.4K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS75886F1075
Valuation
P/E (Trailing)20.44
P/E (Forward)13.64
PEG1.39
EV/EBITDA16.43
EV/Revenue4.97
P/S5.48
P/B2.62
EPS (TTM)39.76
EPS (Forward)60.61
52W Range
541.0097% of range844.90
52W High844.90 USD
52W Low541.00 USD
Profitability
Gross Margin85.35%
Oper. Margin33.11%
EBITDA Margin30.27%
Profit Margin31.41%
ROE14.41%
ROA11.11%
Growth
Revenue Growth16.70%
Earnings Growth-4.50%
Cash Flow & Leverage
Operating CF4.98B $
CapEx (TTM)1.21B $
FCF Margin19.73%
FCF Yield3.60%
Net Debt-5.29B $
Net Debt/EBITDA-1.12
Balance Sheet
Debt/Equity0.09
Current Ratio3.33
Quick Ratio2.63
Book Value/Sh316.11 USD
Cash/Share80.06 USD
Dividends
Fwd Div Rate3.760 USD
Trail. Div Rate3.640 USD
Div. Yield0.45%
5Y Avg Yield—
Payout Ratio9.01%
Ex-Div DateAug 18, 2026
Pay DateAug 31, 2026
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)840.43 USD
Upside (mean)+0.4%
Target Range730.00 USD – 1030.00 USD
$730.00+0.4% to mean$1030.00
# Analysts27
Ownership
Shares Out.101.14M
Float95.78M
Insiders2.08%
Institutions93.46%
Short Interest
Short Ratio4.2d
Short % Float3.48%
Short % Out.3.29%
Shares Short3.39M
Short (prev mo.)3.49M
Technical
SMA 50691.62 (+21.0%)
SMA 200723.49 (+15.7%)
Beta0.19
S&P 52W Chg18.16%
Avg Vol (30d)694.88K
Avg Vol (10d)736.79K
Technical Indicators
RSI (14)75.4
MACD40.6090
MACD Signal36.7848
MACD Hist.+3.8242
BB Upper875.03 USD
BB Middle759.88 USD
BB Lower644.72 USD
BB Width30.31%
ATR (14)20.78 USD
Vol Ratio (20d)0.71x